Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
0.1799
Aug 19 • 10:34 AM ET Dollar change+0.0047 Percentage change(2.68%)
Index
-
Market Cap
3.58M
Enterprise Value
22.22M
Income
-18.31M
Sales
1.05M
Book/sh
-0.53
Cash/sh
0.00
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
2
IPO
Dec 06, 2016
P/E
-
Forward P/E
-
PEG
-
P/S
3.41
P/B
-
P/C
89.59
P/FCF
-
EV/EBITDA
-
EV/Sales
21.17
Quick Ratio
0.09
Current Ratio
0.11
Debt/Eq
0.13
LT Debt/Eq
0.01
Option/Short
No / Yes
EPS (ttm)
-8.25
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
33.45% 25.06%
Sales past 3/5Y
- -
EPS Y/Y TTM
75.73%
Sales Y/Y TTM
-21.23%
EPS Q/Q
97.78%
Sales Q/Q
-100.00%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
7.37%
Insider Trans
0.00%
Inst Own
4.02%
Inst Trans
3.31%
ROA
-78.94%
ROE
-214.52%
ROIC
-180.84%
Gross Margin
44.40%
Oper. Margin
-733.08%
Profit Margin
-1743.75%
SMA20
-13.43%
SMA50
-32.30%
SMA200
-75.51%
Trades
Shs Outstand
13.68M
Shs Float
13.46M
52W High
2.90 -93.79%
52W Low
0.16 9.23%
Volatility
14.45% 12.91%
ATR (14)
0.03
RSI (14)
34.78
Beta
-0.04
Rel Volume
0.36
Avg Volume
1.50M
Volume
129,875
Perf Week
-21.78%
Perf Month
-36.21%
Perf Quarter
-39.43%
Perf Half Y
-75.59%
Perf YTD
-85.01%
Perf Year
-91.14%
Perf 3Y
-98.97%
Perf 5Y
-99.87%
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.18
Price
0.18
Change %
2.68%
Aug-11-26 08:45AM
Aug-04-26 09:00AM
Jul-21-26 08:30AM
Jul-15-26 09:00AM
Jun-16-26 09:00AM
08:00AM Loading…
Jun-04-26 08:00AM
Apr-21-26 08:30AM
Mar-31-26 09:00AM
Mar-02-26 05:23AM
Feb-27-26 05:30PM
08:57AM
Feb-26-26 09:20PM
03:54PM
10:09AM
08:30AM
08:01AM Loading…
08:01AM
Feb-18-26 08:00AM
Feb-02-26 09:00AM
Jan-22-26 09:00AM
Jan-21-26 09:35AM
Jan-20-26 09:00AM
Jan-12-26 09:00AM
Dec-30-25 09:00AM
Dec-15-25 08:30AM
08:20AM
Dec-01-25 09:00AM
Aug-28-25 09:00AM
Jul-28-25 09:00AM
Jul-14-25 08:00AM
Jun-26-25 08:00AM
08:00AM Loading…
Apr-29-25 08:00AM
Apr-15-25 08:00AM
Apr-10-25 08:00AM
Apr-01-25 09:00AM
Mar-10-25 08:00AM
Feb-27-25 08:00AM
Feb-18-25 09:00AM
Nov-21-24 09:00AM
Nov-18-24 09:00AM
Oct-31-24 09:00AM
Oct-25-24 09:00AM
08:31AM
Oct-24-24 09:00AM
Oct-09-24 09:00AM
Aug-14-24 08:00AM
07:30AM
Jul-31-24 08:00AM
Jul-18-24 09:00AM
Jun-21-24 07:30AM
Jun-20-24 08:30AM
Jun-04-24 11:00AM
08:55AM
07:28AM
Jun-03-24 02:53PM
May-24-24 05:00PM
May-21-24 08:30AM
Apr-22-24 09:00AM
Apr-16-24 09:52AM
Mar-28-24 09:00AM
Dec-18-23 09:00AM
Oct-18-23 09:00AM
Oct-04-23 09:00AM
Sep-13-23 09:15AM
Sep-05-23 08:00AM
Aug-30-23 10:45AM
09:00AM
Aug-21-23 09:00AM
Jul-24-23 09:00AM
Jul-19-23 09:00AM
Jul-10-23 09:00AM
Apr-27-23 09:00AM
Apr-17-23 09:00AM
Apr-11-23 09:00AM
Mar-03-23 09:00AM
Feb-13-23 09:00AM
Jan-17-23 09:00AM
Jan-11-23 09:00AM
Jan-03-23 09:00AM
Dec-14-22 09:00AM
Dec-12-22 09:00AM
Change Agents Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
Interim CEOMs. Meng Li
Chief Strategy OfficerMs. Luisa Ingargiola
Chief Financial OfficerMr. Samuel J. Knipper